Dingliang Zhu Selected Research

Receptor for Advanced Glycation End Products

1/2013	Association of four genetic polymorphisms of AGER and its circulating forms with coronary artery disease: a meta-analysis.
7/2012	A meta-analysis of receptor for advanced glycation end products gene: four well-evaluated polymorphisms with diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dingliang Zhu Research Topics

Disease

17	Hypertension (High Blood Pressure) 12/2018 - 06/2005
9	Essential Hypertension 02/2014 - 05/2002
7	Stroke (Strokes) 01/2019 - 09/2014
4	Pathologic Constriction (Stenosis) 01/2019 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2013
2	Ischemic Stroke 04/2015 - 01/2015
2	Cognitive Dysfunction 09/2014 - 09/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2013 - 05/2012
2	Diabetes Mellitus 01/2013 - 07/2012
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 12/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Vascular Diseases (Vascular Disease) 12/2016
1	Hyperaldosteronism (Conn Syndrome) 09/2016
1	Inflammation (Inflammations) 01/2014
1	Vascular Ring 01/2014
1	Edema (Dropsy) 01/2014
1	Left Ventricular Dysfunction 03/2013
1	Obesity 02/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2013
1	Atherosclerotic Plaque (Atheroma) 02/2013
1	Atherosclerosis 02/2013
1	Chronic Renal Insufficiency 02/2012
1	Lung Neoplasms (Lung Cancer) 01/2012
1	Breast Neoplasms (Breast Cancer) 11/2010
1	Glucose Intolerance 08/2010
1	Insulin Resistance 08/2010
1	Type 2 Diabetes Mellitus (MODY) 01/2010

Drug/Important Bio-Agent (IBA)

9	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 06/2005
5	Telmisartan (Micardis)FDA Link 06/2014 - 01/2013
3	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 06/2014 - 01/2013
2	AlbuminsIBA 01/2019 - 02/2012
2	CreatinineIBA 01/2019 - 02/2012
2	HomocysteineIBA 12/2018 - 08/2016
2	LDL CholesterolIBA 09/2014 - 09/2014
2	oxidized low density lipoproteinIBA 09/2014 - 09/2014
2	Amlodipine (Norvasc)FDA LinkGeneric 02/2014 - 01/2014
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2014 - 05/2002
2	Receptor for Advanced Glycation End ProductsIBA 01/2013 - 07/2012
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2018
1	lysophosphatidic acidIBA 01/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2016
1	PotassiumIBA 09/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2015
1	Enalapril FDA LinkGeneric 04/2015
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2015
1	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 06/2014
1	arotinolol (S 596)IBA 01/2014
1	arginine methyl esterIBA 01/2014
1	CollagenIBA 01/2014
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2014
1	Valsartan (Vals)FDA Link 09/2013
1	Valsartan Drug Combination Amlodipine FDA Link 09/2013
1	Mineralocorticoid Receptor AntagonistsIBA 03/2013
1	plasmin receptorIBA 02/2013
1	Fibrinolysin FDA Link 02/2013
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2013
1	AdipokinesIBA 02/2013
1	LipidsIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Interleukin-6 (Interleukin 6)IBA 05/2012
1	NAD (NADH)IBA 01/2012
1	NADP (NADPH)IBA 01/2012
1	Oxidoreductases (Dehydrogenase)IBA 01/2012
1	quinone (benzoquinone)IBA 01/2012
1	kynureninaseIBA 12/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2010
1	Ligases (Synthetase)IBA 10/2010
1	ApelinIBA 09/2010
1	Glucose (Dextrose)FDA LinkGeneric 08/2010
1	Bradykinin B2 ReceptorIBA 03/2010
1	CatalaseIBA 03/2010
1	ReninIBA 01/2010
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2010
1	Apolipoproteins E (ApoE)IBA 12/2009
1	Apolipoprotein E4IBA 12/2009
1	ORALIT (ORS)IBA 12/2009
1	Apolipoprotein E3IBA 12/2009
1	ApolipoproteinsIBA 12/2009
1	Apolipoprotein E2IBA 12/2009
1	CytokinesIBA 06/2002
1	Endothelins (Endothelin)IBA 05/2002
1	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2002

Therapy/Procedure

5	Therapeutics 04/2015 - 01/2013
1	Adrenalectomy 09/2016
1	Duration of Therapy 04/2015
1	Secondary Prevention 09/2014